
Last updated: 2026-10-12 03:25:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Cellyan Biotechnology Co., Ltd (HKPD) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $0,11, with a market capitalization of $5,52M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0,09 to $1,72. This page covers its latest market performance, valuation, price trends and company information.
$5,52M | |
$0,10 | |
$3,79 | |
$0,09 | |
$0,10 | |
378,26K | |
3,84M | |
-- | |
$1,72 | |
$0,09 | |
-- | |
-- |
Cellyan Biotechnology Co., Ltd (HKPD) last closed at $0,10 as of 2026-10-09 23:52:00, unchanged from the previous close of $0,10.
During the latest regular trading session, HKPD traded between $0,09 and $3,79, with a volume of 378,26K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, Cellyan Biotechnology Co., Ltd (HKPD) moved from $0,11 to $0,11, representing a gain of 1,07% ($0,00).
The stock traded between $0,09 and $0,12 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.
The average daily volume was 731,39 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 1,1%
HKPD is currently trading at $0,11, placing it 1,1% of the way from its 52-week low of $0,09 to its 52-week high of $1,72. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Cellyan Biotechnology Co Ltd is an integrated pharmaceutical cross-border e-commerce supply chain service provider with a professional team and related pharmaceutical storage facilities in Hong Kong. It operates through two main categories: OTC pharmaceutical cross-border e-commerce supply chain services, referred to as the Supply Chain Services division, and OTC pharmaceutical cross-border procurement and distribution, referred to as the Procurement and Distribution division. Its main business provides one-stop services for merchants engaged in cross-border pharmaceutical e-commerce, including OTC wholesale, import and export, warehousing, packaging, customs clearance and delivery to final destinations, forming a closed loop of pharmaceutical cross-border e-commerce supply chain.
| Employees | 11 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Cellyan Biotechnology Co., Ltd (HKPD) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.